Intravitreal Triamcinolone Acetonide for Refractory Diabetic Macular Oedema

Early Treatment Diabetic Retinopathy Study Research Group. Retinopathy Study report number 1. Arch Ophthalmol 1985; 103: 1796–806

Klein R. , Klein B.E.K. , Moss S.E. . The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 1984; 91: 1464–74

Wilson C.A. , Berkowitz B.A. , Sato Y. . Treatment with intravitreal steroid reduces blood–retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155–9

Martidis A. , Duker J.S. , Greenberg P.B. . Intravitral triamcinolone for refractory diabetic diffuse macular edema. Ophthalmology 2002; 109: 920–7

Massin P. , Audren F. , Haouchine B. . Intravitral triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 2004; 111: 218–25

Jonas J.B. , Kreissig I. , Sofker A. , Degenring R.F. Intravitral injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003; 121: 57–61

Young S. , Larkin G. , Branley M. , Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29: 2–6